Skip to main content Skip to navigation

Multiple Sclerosis Trials Collaboration (mstc)

Also known as: Mstc

To provide patients with MS who are not suitable for current therapies, access to pharmaceutical-sponsored clinical trials. Furthermore, to use generated income by undertaking pharmaceutical clinical trials to devise & administer research-led clinical trials thereby providing greater access to potential treatments to more MS patients.

Email Charity

Activities & Mission

To provide patients with MS who are not suitable for current therapies, access to pharmaceutical-sponsored clinical trials. Furthermore, to use generated income by undertaking pharmaceutical clinical trials to devise & administer research-led clinical trials thereby providing greater access to potential treatments to more MS patients.

Areas of Operation

Where this charity is registered to operate, as self-declared to the Charity Commission. These are regulatory classifications, not a list of active programmes, and don't necessarily indicate fundraising activity in each location.

Financial Information

Latest Income
£50,628
Latest Expenditure
£3,992

Financial Efficiency

Overall Efficiency 7.9%
% of expenditure going to programs (vs overhead)
Expenditure Ratio 7.9%
Expenditure as % of income

Financial Trend

Annual Returns

As filed with the Charity Commission for England and Wales. Most recent filing covers the financial year ending 2025.

Financial YearIncomeExpenditureCharitable SpendingNet AssetsReservesStaff
2025
£50,628
£3,9920 / 0
2024
£50,551
£16,0790 / 0
2023
£102,588
£51,2480 / 0
2022
£57,770
£26,1390 / 0

Staff column shows: Employees / Volunteers

Frequently asked questions about Multiple Sclerosis Trials Collaboration (mstc)

What does Multiple Sclerosis Trials Collaboration (mstc) do?

To provide patients with MS who are not suitable for current therapies, access to pharmaceutical-sponsored clinical trials. Furthermore, to use generated income by undertaking pharmaceutical clinical trials to devise & administer research-led clinical trials thereby providing greater access to potential treatments to more MS patients.

How much income did Multiple Sclerosis Trials Collaboration (mstc) report in 2025?

Multiple Sclerosis Trials Collaboration (mstc) reported total income of £51k and reported expenditure of £4k for the financial year ending 2025, based on the most recent annual return filed with the Charity Commission.

When was Multiple Sclerosis Trials Collaboration (mstc) registered as a charity?

Multiple Sclerosis Trials Collaboration (mstc) was registered with the Charity Commission for England and Wales on 5 April 2006 as charity number 1113598. It has been registered for 20 years.

Who runs Multiple Sclerosis Trials Collaboration (mstc)?

Multiple Sclerosis Trials Collaboration (mstc) is governed by a board of 3 trustees. Trustees are legally responsible for the charity's governance and are listed in full on its profile.

Where does Multiple Sclerosis Trials Collaboration (mstc) operate?

Multiple Sclerosis Trials Collaboration (mstc) operates in Hammersmith And Fulham, as recorded in its Charity Commission filing.

Is Multiple Sclerosis Trials Collaboration (mstc) a registered charity?

Yes — Multiple Sclerosis Trials Collaboration (mstc) is a registered charity in England and Wales, charity number 1113598.

Details

Address
17 FLOYER CLOSE
RICHMOND
TW10 6HS
Registration Date
5 April 2006
Status
Registered

Registry Information

Organisation Number
4021203
Charity Number
1113598

Is this your charity?

Add your logo, photos and tell the story behind the numbers in your own words. Free for our first 50 launch partners.

Claim this listing Learn more about premium profiles

Trustees

Dr OMAR MALIK
Dr RICHARD ST JOHN NICHOLAS
JEREMY CHATAWAY

Sectors & Classifications

Also Known As

  • Mstc

Data & trust

Register data refreshed
14 May 2026
Report a data issue